{
  "api": "2.0",
  "content": {
    "html": "<h1 id='0' style='font-size:22px'>감염단핵구증</h1>\n<p id='1' data-category='paragraph' style='font-size:20px'>개요</p>\n<br><figure id='2'><img style='font-size:16px' alt=\"건강담기 수정 문의\" data-coord=\"top-left:(933,0); bottom-right:(1215,33)\" /></figure>\n<p id='3' data-category='paragraph' style='font-size:14px'>■ 등록일자 : 2020-07-22 ■ 업데이트: 2021-01-15 ■ 조회 : 11629 정보신청 100</p>\n<h1 id='4' style='font-size:20px'>개요</h1>\n<p id='5' data-category='paragraph' style='font-size:18px'>감염단백구 증(infectious mononucleosis]은 열이 나고 간과 비장, 림프절이 커지는 병입니다. 1920년 스프런트(Sprunt)와 에반스(Evans)가 발열, 피로와 함께<br>림프절이 커지는 젊은 성인 6명을 보고하면서 감염단핵구증이라는 질병이 알려졌습니다. 1960년대 앱스타인(Epstein), 아슘(Achang), 바(Barr) 등에 의해<br>앱스타인-바 바이러스(Epatein-Barr virus, EBV)가 질병의 원인임이 밝혀졌습니다.</p>\n\n<br><figure id='7'><img style='font-size:14px' alt=\"발열\n피로 권태료\n침물 설립 대\n특히 따기를\n틸프림이\n부여오름\n(엘스타인-마 바이러스 감염)\nII pr MIN Barr YELL EBV)\" data-coord=\"top-left:(354,392); bottom-right:(925,723)\" /><figcaption id='6' style='font-size:16px'>(그림 감염단백구중)</figcaption></figure>\n<h1 id='8' style='font-size:20px'>개요-종류</h1>\n<br><p id='9' data-category='paragraph' style='font-size:18px'>감염단핵구종의 90%는 앱스타인-바 바이러스에 의해 발생합니다. 나머지 10%는 다른 원인에 의해 발생하는데, 원인 미생물로 사람면역결핍바이러스,<br>거대세포바이러스, 록소포자증, 사람 헤르페스바이러스 6형, B형 간염바이러스 등이 알려졌습니다.</p>\n<h1 id='10' style='font-size:18px'>1. 사람면역결핍바이러스 감염증[HIV감염증]</h1>\n<p id='11' data-category='paragraph' style='font-size:18px'>사람면역결핍바이러스(human immunodeficiency virus. HIV) 감염 초기에 감염단백구증과 비슷한 발열, 인후통, 근육통, 림프절 비대 등이 나타날 수 있습니다.<br>앱스타인-바 바이러스에 의한 감염단백구증은 점막(입안, 결막, 성기 주변) 궤양이 드물고, 피부 발진도 흔하지 않으나 항생제를 복용한 경우 자주 생깁니다.<br>사람면역결핍바이러스 감염증은 엘이 난 지 48- 72시간 안에 발진이 나타나는 경우가 더 혼합니다.</p>\n<h1 id='12' style='font-size:18px'>2. 거대세포바이러스 감염증(CMV감염증)</h1>\n<p id='13' data-category='paragraph' style='font-size:18px'>거대세포바이러스(cytomegalovirus, CMV)는 엡스타인-바 바이러스에 의한 감염단백구증에 비해 발열이 주증상이며, 림프절 비대와 인후통은 덜 혼합니다. 간<br>효소 수치의 가벼운 증가는 자주 관찰되지만, 황달이나 심각한 간염 증상은 드물게 나타납니다.</p>\n<p id='14' data-category='paragraph' style='font-size:16px'>3. 록소포자중증</p>\n<p id='15' data-category='paragraph' style='font-size:18px'>톡소포자중증은 톡소포자라고 불리는 기생중에 의한 감염증으로 발열과 림프절 비대가 특징입니다. 인후염은 거의 없으며, 거대세포바이러스나 앱스타인 -바<br>바이레스 감염 시 흔히 나타나는 간기능검사 이상이나 혈액검사 이상도 드뭅니다.</p>\n<p id='16' data-category='paragraph' style='font-size:18px'>사람 헤르페스바이러스(Herpes simplex virus. HSV) 6형이나 7형에 의한 일차 감염증은 성인에서 드물지만, 림프절 비대 등 감염단백구증과 유사한 증상이<br>나타날 수 있습니다.</p>\n<br><h1 id='17' style='font-size:18px'>4. 사람 헤르메스바이러스 감염증(HSV감염증)</h1>\n<h1 id='18' style='font-size:22px'>개요-원인</h1>\n<br><p id='19' data-category='paragraph' style='font-size:18px'>감염단핵구증의 90%는 엠스타인-바 바이러스에 의해 발생합니다. 엠스타인-바 바이러스는 감마 헤르페스바이러스에 속하며 크게 1형과 2형으로 구분됩니다. 두<br>가지 유형은 70- 85%의 염기서열 유사성을 가지고 있습니다. 1형은 전 세계에 퍼져 있고, 2형은 주로 아프리카에 분포합니다. 엠스타인-바 바이러스는 감염된<br>사람의 침으로 분비되어 전파됩니다. 증상이 나타나지 않은 성인이 신생아나 어린이 혹은 다른 성안에게 입을 맞줄 때 쉽게 전파될 수 있습니다. 밀접한 접촉이<br>없다면 전파되기 어렵습니다. 감염단백구증의 나머지 10%는 거대세포바이러스, 사람면역결핍바이러스, 톡소포자총, 사람 헤르페스바이러스 6형, B형<br>간염바이러스 등 다른 미생물에 의해 발생합니다.</p>\n<h1 id='20' style='font-size:20px'>역학 및 통계</h1>\n<p id='21' data-category='paragraph' style='font-size:18px'>감염단핵구증은 전 세계적으로 나타나는데 선진국에서는 청소년 및 젊은 성인에서 주로 발생합니다. 반면 우리나라, 일본, 중국 동부 등 극동아시아 지역에서는<br>어린 소아에게 많이 발생하며, 임상적으로 증상이 없거나 경한 것이 특징입니다. 국내 면역혈청학적 연구 결과, 모체에서 전달된 엡스타인-바 바이 러스 항체는<br>생후 7개월경에 완전히 소심되지만 생후 10개월부터 초감염이 시작되어 5세경에는 50%, 10세에 이르면 거의 모든 소아가 옙스타인-바 바이러스에 감염됩니다.</p>\n<br><p id='22' data-category='paragraph' style='font-size:16px'>1. 역학</p>\n<br><header id='23' style='font-size:14px'>2. 전파</header>\n<p id='24' data-category='paragraph' style='font-size:14px'>대표적으로 침과 같은 구강 분비물에 의한 전파, 모유수유에 의한 전파, 성접촉에 의한 전파가 가능합니다. 엡스타인-바 바이러스에 감염된 환자는 일반적으로<br>증상이 나타난 후 6개월까지 바이러스를 전파할 수 있습니다. 환자의 접촉자가 비접촉자에 비해 엡스타인-바 바이러스에 감염될 확률이 높지는 않은 것으로 되어<br>있어 관리가 필요한 전염병으로 분류되지는 않습니다.</p>\n<p id='25' data-category='paragraph' style='font-size:18px'>증상</p>\n<p id='26' data-category='paragraph' style='font-size:14px'>신생아나 소아는 엡스타인-바 바이러스에 감염되어도 대부분 증상이 없거나 가볍습니다. 후진국이나 개발도상국 혹은 위생 상태가 좋지 않은 환경에서는 대부분<br>신생아나 소아기에 엡스타인-바 바이러스에 감염되기 때문에 청소년이나 성인이 감염되는 경우는 거의 없습니다. 하지만 선진국이나 청결한 환경에 사는<br>사람들은 청소년기나 성인이 되어 엡스타인-바 바이러스에 처음 감염되는 경우가 흔하고, 이런 경우 증상을 동반한 감염단핵구증이 발생할 수 있습니다.</p>\n<p id='27' data-category='paragraph' style='font-size:14px'>젊은 성인이 엡스타인-바 바이러스에 감염되면 4-6주간의 무증상 잠복기를 거쳐 피로감, 권태감 및 근육통이 약 1-2주 동안 지속됩니다. 이후 발열, 인후통 및<br>림프절 비대가 발생합니다.</p>\n<p id='28' data-category='paragraph' style='font-size:18px'>진단 및 검사</p>\n<p id='29' data-category='paragraph' style='font-size:14px'>엡스타인-바 바이러스와 연관된 감염단핵구증은 청소년이나 젊은 성인에서 인후통, 발열, 권태감과 함께 림프절 비대와 인후염이 진찰로 확인되면 의심할 수<br>있습니다. 의사는 자세한 문진과 함께 진찰을 통해 환자의 증상과 징후를 평가합니다. 진찰로 감염단핵구증이 의심되면 엡스타인-바 바이러스에 대한 혈액 검사를<br>시행합니다. 혈액 검사에서 림프구수나 비정형 림프구수가 증가하고, 이종친화항체가 양성이면 감염단핵구증으로 진단할 수 있습니다. 그 외 엡스타인-바<br>바이러스 특이 항체검사가 필요하기도 합니다. 목 주변 림프절이 커지지 않거나 피로감이 없는 환자는 입 천장에 점 모양의 출혈이 있거나 비장이 커지는 경우<br>의심할 수 있습니다. 그러나 이런 증상이 있어 감염단핵구증이 의심되더라도 발열, 림프절 비대, 인후염이 있을 때는 화농성 사슬알균에 의한 세균성 인후염을<br>먼저 고려해야 합니다.</p>\n<p id='30' data-category='paragraph' style='font-size:14px'>1. 문진</p>\n<p id='31' data-category='paragraph' style='font-size:14px'>열이 얼마나 나는지, 목이 따가운지, 아프고 부은 림프절이 있는지, 피부 발진이 있는지 등을 묻습니다.</p>\n<p id='32' data-category='paragraph' style='font-size:14px'>2. 진찰</p>\n<p id='33' data-category='paragraph' style='font-size:14px'>감염단핵구증은 전신을 침범하는 질환이므로 전신을 진찰합니다. 입안을 진찰하여 인후염이 있는지, 편도가 커져 있는지 확인합니다. 목의 림프절을 포함하여<br>전신 림프절이 커지고 부었는지 확인합니다. 가슴을 청진하여 폐렴이나 흉수가 있는지 확인하고, 배에서 간이나 비장이 커졌는지를 확인합니다. 전신에 발진이<br>있는지도 확인합니다. 그 외에 신경증상이 있는 경우 신경학적 검사를 통해 마비가 동반되었는지 확인합니다.</p>\n<p id='34' data-category='paragraph' style='font-size:14px'>3. 피검사 소견</p>\n<p id='35' data-category='paragraph' style='font-size:14px'>1) 혈액검사 이상</p>\n<br><p id='36' data-category='paragraph' style='font-size:14px'>가장 흔한 검사 이상은 말초 혈액에서 림프구수 증가(림프구증가증)입니다. 림프구증가증은 말초혈액 림프구의 절대수가 4,500개/uL 이상, 혹은 말초혈액<br>도말검사에서 림프구 분획이 백혈구의 50% 이상일 때로 정의됩니다. 모양이 이상한 비정형 림프구가 전체 림프구수의 10% 이상인 것을 말초혈액 도말검사에서<br>확인할 수 있습니다. 정상인의 말초혈액에서 총 백혈구수는 4,000-10,000개/uL이나, 감염단핵구증에서는 12,000-18,000개/uL로 증가합니다. 일부<br>환자에서는 경미한 호중구감소증과 혈소판감소증이 나타날 수 있습니다. 이러한 현상은 대개 특별한 치료제를 투여하지 않아도 저절로 회복됩니다. 드물게<br>용혈성 빈혈, 혈소판감소증, 악성 빈혈이나 혈전저혈소판혈증자색반병, 용혈요독증후군, 파종혈관내응고 등이 발생할 수 있습니다.</p>\n<p id='37' data-category='paragraph' style='font-size:14px'>2) 간기능 검사</p>\n<br><p id='38' data-category='paragraph' style='font-size:14px'>간효소 중 하나인 아미노 전이효소치의 상승은 많은 환자에서 관찰되며 대개 저절로 좋아집니다.</p>\n<p id='39' data-category='paragraph' style='font-size:14px'>4. 감별진단</p>\n<p id='40' data-category='paragraph' style='font-size:14px'>발열, 인후통, 림프절 비대 등은 감염단핵구증에서만 나타나는 특이한 증상은 아닙니다. 엡스타인-바 바이러스 외에 세균성 인후염을 잘 일으키는 화농성<br>사슬알균 감염증이나 거대세포바이러스, 사람면역결핍바이러스 등 다른 바이러스 감염증에서도 나타날 수 있습니다. 비정형 림프구가 나타나는 단핵구 증후군은<br>감염증 외에 항경련제인 페니토인, 카바마제핀, 항결핵제인 이소니아지드, 항생제인 미노사이클린 등 약제에 의해 발생하기도 합니다.</p>\n<p id='41' data-category='paragraph' style='font-size:14px'>5. 진단에 도움을 주는 검사</p>\n<p id='42' data-category='paragraph' style='font-size:14px'>1) 혈액검사 소견</p>\n<br><p id='43' data-category='paragraph' style='font-size:14px'>가장 흔한 검사 이상 소견은 말초 혈액에서 림프구수 증가입니다. 말초혈액 도말검사에서 비정형 림프구가 전체 림프구수의 10% 이상을 차지하면 진단에 도움이<br>됩니다. 하지만 비정형 림프구는 감염단핵구증 외에도 톡소플라즈마 감염, 풍진, 장미진, 볼거리, 거대세포바이러스 등 바이러스 감염증과 급성<br>사람면역결핍바이러스 증후군, 급성 바이러스 간염 등 다른 감염질환에서도 나타날 수 있습니다.</p>\n<p id='44' data-category='paragraph' style='font-size:14px'>2) 이종친화항체(heterophil antibody) 검사</p>\n<br><p id='45' data-category='paragraph' style='font-size:14px'>이종친화항체는 서로 다른 종의 항원에 반응하는 항체로, 이종친화항체 검사는 환자의 혈청이 양, 말, 소, 염소의 적혈구와 반응하여 응집하는지를 확인하는<br>검사법입니다. 감염단핵구증의 증상이 있는 환자에서 이종친화항체 검사 결과가 양성이면 감염단핵구증으로 확진할 수 있습니다. 증상이 있고 이종친화항체가<br>양성으로 확인된 환자는 엡스타인-바 바이러스에 대한 특이 항체 검사가 필요 없습니다. 일부 환자는 임상적으로 의심은 되는데 검사 결과가 음성으로 나오기도</p>\n<p id='46' data-category='paragraph' style='font-size:16px'>합니다. 증상이 시작되는 첫 주에 위음성(감염단핵구증이지만 검사 결과가 음성인 경우)이 가장 흔하여 25%에 달하고, 2주째는 5-10%, 3주째는 5%로<br>떨어집니다. 따라서, 임상적으로 감염단핵구증이 강력히 의심되면 검사를 다시 하여 양성으로 바뀌는지 확인하는 것이 좋습니다.</p>\n<p id='47' data-category='list' style='font-size:16px'>3) 엡스타인-바 바이러스 특이 항체<br>감염단핵구증이 의심되지만 이종친화항체가 음성인 경우 엡스타인-바 바이러스에 대한 특이 항체를 검사합니다. 바이러스 캡시드 항원에 대한 면역글로불린<br>M(Immunoglobulin M, IgM)과 면역글로불린 G(Immunoglobulin G, IgG) 항체는 감염단핵구증 진단에 유용한 검사법입니다.</p>\n<p id='48' data-category='paragraph' style='font-size:16px'>(1) 바이러스 캡시드 항원(virus capsid antibody, EBV VCA)</p>\n<br><p id='49' data-category='paragraph' style='font-size:16px'>엡스타인-바 바이러스 캡시드 항원에 대한 IgM과 IgG 항체는 임상 증상이 나타나는 초기에 대개 양성으로 나타납니다. IgM 항체는 증상 발생 후 3개월까지<br>나타나기도 합니다. 따라서, IgM 항체는 급성 감염증의 좋은 지표입니다. IgG 항체는 평생 지속됩니다. 따라서 급성 감염증의 좋은 지표는 아니지만 감염된 적이<br>있다는 증거가 됩니다.</p>\n<p id='50' data-category='paragraph' style='font-size:16px'>(2) 핵 항원(nuclear antibody, EBNA)</p>\n<br><p id='51' data-category='paragraph' style='font-size:16px'>엡스타인-바 바이러스의 핵 항원에 대한 IgM 항체가 있는 경우 급성 엡스타인-바 바이러스 감염증으로 진단할 수 있습니다. IgG 항체는 증상 발현 6-12주에<br>나타나기 시작하여 평생 지속됩니다. 따라서, 시간이 지나면서 엡스타인-바 바이러스 핵 항원 IgG가 음성에서 양성으로 바뀌면 확진할 수 있습니다.</p>\n<p id='52' data-category='paragraph' style='font-size:16px'>(3) 초기 항원(early antigen, EA)</p>\n<br><p id='53' data-category='paragraph' style='font-size:16px'>초기 항원에 대한 IgG 항체는 증상이 발생하는 시점에 양성으로 나타납니다. 초기 항원에는 D항원에 대한 초기 IgG 항체와 R항원에 대한 초기 IgG 항체 등 두<br>가지가 있습니다. D항원에 대한 항체는 감염 초기에 역가가 상승했다가 회복기를 거치면서 음성으로 변합니다. 그러나 대다수 환자에서 나타나는 항체는<br>아니므로, D항원에 대한 항체가 음성이라도 급성 엡스타인-바 바이러스 감염증을 배제할 수 없습니다. R항원에 대한 IgG 항체는 일부 환자만 양성으로<br>나타납니다.</p>\n<p id='54' data-category='paragraph' style='font-size:16px'>4) 엡스타인-바 바이러스 중합효소연쇄반응(polymerase chain reaction, PCR)</p>\n<br><p id='55' data-category='paragraph' style='font-size:16px'>혈액으로 중합효소연쇄반응을 검사하여 엡스타인-바 바이러스 유전자를 확인할 수 있습니다. 중합효소연쇄반응은 원하는 유전자를 복제·증폭시키는<br>분자생물학적 기술입니다. 혈액 속바이러스 유전자를 검사하여 바이러스가 얼마나 있는지 정량합니다. 그러나 병원에서 감염단핵구증을 진단하기 위해 이 검사가<br>필요하지는 않습니다.</p>\n<header id='56' style='font-size:20px'>치료</header>\n<p id='57' data-category='paragraph' style='font-size:16px'>1. 대증치료</p>\n<p id='58' data-category='paragraph' style='font-size:16px'>감염단핵구증의 주된 치료는 증상을 가라앉히는 대증치료입니다. 발열, 인후통, 근육통, 권태감이 심한 경우 진통해열제가 도움이 됩니다. 충분한 수분과 영양<br>섭취도 중요하며, 휴식을 취하는 것이 좋습니다. 스테로이드 치료를 하는 경우가 있는데, 합병증이 생기지 않은 감염단핵구증에는 사용하지 않습니다.<br>스테로이드를 불필요하게 사용하면 이차 세균감염증이 잘 발생하기 때문입니다.</p>\n<p id='59' data-category='paragraph' style='font-size:16px'>2. 합병증이 동반된 감염단핵구증의 치료</p>\n<p id='60' data-category='paragraph' style='font-size:16px'>편도가 심하게 부어 기도가 막힐 위험이 있는 경우 스테로이드를 사용합니다. 매일 프레드니솔론 40~60 mg을 2-3일 투여한 후, 1-2주에 걸쳐 천천히 줄입니다.<br>그 외에 자가면역 용혈성 빈혈, 심한 혈소판감소증, 간부전을 동반한 심한 간염이 있는 경우에도 스테로이드 치료를 합니다.</p>\n<p id='61' data-category='paragraph' style='font-size:16px'>3. 항바이러스제 치료</p>\n<p id='62' data-category='paragraph' style='font-size:16px'>아시클로버(acyclovir)는 항바이러스제로 엡스타인-바 바이러스 DNA 유전자중합효소를 억제하여 바이러스 증식을 막습니다. 항바이러스제를 투여하면<br>입안에서 바이러스 배출이 억제되지만, 병의 심한 정도나 증상의 기간을 감소시키지 않으며 궁극적인 예후에도 영향을 주지 않습니다. 따라서 감염단핵구증<br>치료로 항바이러스제 투여는 추천되지 않습니다.</p>\n<p id='63' data-category='paragraph' style='font-size:20px'>합병증</p>\n<p id='64' data-category='paragraph' style='font-size:16px'>지속적인 피곤함과 불편감, 신체 장애 등의 증상이 수 주에서 6개월까지 호전과 악화를 반복할 수 있습니다. 드물게 비장 파열, 2차 감염, 간기능 부전, 심근염이<br>발생할 수 있으며, 이러한 경우에 사망하기도 합니다. 이런 중증 합병증은 소아에서는 극히 드물며 젊은 성인에서 많이 나타납니다.</p>\n<p id='65' data-category='paragraph' style='font-size:20px'>참고문헌</p>\n<p id='66' data-category='paragraph' style='font-size:16px'>1. Section 4-4. 엡스타인 바이러스, 감염학, 2014</p>\n<p id='67' data-category='paragraph' style='font-size:16px'>3. Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015;390(Pt 1):211-240. doi:10.1007/978-3-<br>319-22822-8_9</p>\n<br><p id='68' data-category='paragraph' style='font-size:16px'>2. Fafi-Kremer S, Morand P, Brion JP, et al. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis.<br>2005;191(6):985-989. doi:10.1086/428097</p>\n<p id='69' data-category='paragraph' style='font-size:18px'>본 공공저작물은 공공누리 \"출처표시+상업적이용금지+변경금지\" 조건에 따라 이용할 수 있<br>습니다.</p>\n<p id='70' data-category='paragraph' style='font-size:14px'> 목록</p>\n<br><header id='71' style='font-size:18px'>개인정보처리방침 개인정보이용안내 저작권정책 및 웹접근성</header>\n<p id='72' data-category='list' style='font-size:18px'>[ 28159 ] 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 오송보건의료행정타운 내 질병관리청<br>문의사항: 02-2030-6602 (평일 9:00-17:00, 12:00-13:00 제외) / 관리자 이메일 : nhis@korea.kr</p>\n<br><p id='73' data-category='paragraph' style='font-size:14px'>COPYRIGHT @ 2024 질병관리청. ALL RIGHT RESERVED</p>\n<p id='74' data-category='paragraph' style='font-size:18px'>※ 본 페이지에서 제공하는 내용은 참고사항일 뿐 게시물에 대한 법적책임은 없음을 밝혀드립니다. 자세한 내용은 전문가와 상담하시기 바랍니다.</p>\n<br><p id='75' data-category='paragraph' style='font-size:18px'>해외기관  유관기관  정부기관 </p>\n<figure id='76'><img alt=\"\" data-coord=\"top-left:(2150,140); bottom-right:(2260,224)\" /></figure>",
    "markdown": "",
    "text": ""
  },
  "elements": [
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='0' style='font-size:22px'>감염단핵구증</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.033,
          "y": 0.0144
        },
        {
          "x": 0.1184,
          "y": 0.0144
        },
        {
          "x": 0.1184,
          "y": 0.0319
        },
        {
          "x": 0.033,
          "y": 0.0319
        }
      ],
      "id": 0,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='1' data-category='paragraph' style='font-size:20px'>개요</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0387,
          "y": 0.0471
        },
        {
          "x": 0.0603,
          "y": 0.0471
        },
        {
          "x": 0.0603,
          "y": 0.0595
        },
        {
          "x": 0.0387,
          "y": 0.0595
        }
      ],
      "id": 1,
      "page": 1
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<br><figure id='2'><img style='font-size:16px' alt=\"건강담기 수정 문의\" data-coord=\"top-left:(933,0); bottom-right:(1215,33)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4763,
          "y": 0.0001
        },
        {
          "x": 0.6204,
          "y": 0.0001
        },
        {
          "x": 0.6204,
          "y": 0.0154
        },
        {
          "x": 0.4763,
          "y": 0.0154
        }
      ],
      "id": 2,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='3' data-category='paragraph' style='font-size:14px'>■ 등록일자 : 2020-07-22 ■ 업데이트: 2021-01-15 ■ 조회 : 11629 정보신청 100</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0364,
          "y": 0.0707
        },
        {
          "x": 0.3711,
          "y": 0.0707
        },
        {
          "x": 0.3711,
          "y": 0.0855
        },
        {
          "x": 0.0364,
          "y": 0.0855
        }
      ],
      "id": 3,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='4' style='font-size:20px'>개요</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0338,
          "y": 0.1003
        },
        {
          "x": 0.06,
          "y": 0.1003
        },
        {
          "x": 0.06,
          "y": 0.1147
        },
        {
          "x": 0.0338,
          "y": 0.1147
        }
      ],
      "id": 4,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='5' data-category='paragraph' style='font-size:18px'>감염단백구 증(infectious mononucleosis]은 열이 나고 간과 비장, 림프절이 커지는 병입니다. 1920년 스프런트(Sprunt)와 에반스(Evans)가 발열, 피로와 함께<br>림프절이 커지는 젊은 성인 6명을 보고하면서 감염단핵구증이라는 질병이 알려졌습니다. 1960년대 앱스타인(Epstein), 아슘(Achang), 바(Barr) 등에 의해<br>앱스타인-바 바이러스(Epatein-Barr virus, EBV)가 질병의 원인임이 밝혀졌습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0326,
          "y": 0.1225
        },
        {
          "x": 0.6212,
          "y": 0.1225
        },
        {
          "x": 0.6212,
          "y": 0.158
        },
        {
          "x": 0.0326,
          "y": 0.158
        }
      ],
      "id": 5,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='6' data-category='paragraph' style='font-size:16px'>(그림 감염단백구중)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2911,
          "y": 0.1691
        },
        {
          "x": 0.3625,
          "y": 0.1691
        },
        {
          "x": 0.3625,
          "y": 0.1797
        },
        {
          "x": 0.2911,
          "y": 0.1797
        }
      ],
      "id": 6,
      "page": 1
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<br><figure id='7'><img style='font-size:14px' alt=\"발열\n피로 권태료\n침물 설립 대\n특히 따기를\n틸프림이\n부여오름\n(엘스타인-마 바이러스 감염)\nII pr MIN Barr YELL EBV)\" data-coord=\"top-left:(354,392); bottom-right:(925,723)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.1811,
          "y": 0.1838
        },
        {
          "x": 0.4727,
          "y": 0.1838
        },
        {
          "x": 0.4727,
          "y": 0.3382
        },
        {
          "x": 0.1811,
          "y": 0.3382
        }
      ],
      "id": 7,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='8' style='font-size:20px'>개요-종류</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0334,
          "y": 0.386
        },
        {
          "x": 0.0891,
          "y": 0.386
        },
        {
          "x": 0.0891,
          "y": 0.4016
        },
        {
          "x": 0.0334,
          "y": 0.4016
        }
      ],
      "id": 8,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='9' data-category='paragraph' style='font-size:18px'>감염단핵구종의 90%는 앱스타인-바 바이러스에 의해 발생합니다. 나머지 10%는 다른 원인에 의해 발생하는데, 원인 미생물로 사람면역결핍바이러스,<br>거대세포바이러스, 록소포자증, 사람 헤르페스바이러스 6형, B형 간염바이러스 등이 알려졌습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0336,
          "y": 0.4083
        },
        {
          "x": 0.6219,
          "y": 0.4083
        },
        {
          "x": 0.6219,
          "y": 0.4332
        },
        {
          "x": 0.0336,
          "y": 0.4332
        }
      ],
      "id": 9,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='10' style='font-size:18px'>1. 사람면역결핍바이러스 감염증[HIV감염증]</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0337,
          "y": 0.4533
        },
        {
          "x": 0.1998,
          "y": 0.4533
        },
        {
          "x": 0.1998,
          "y": 0.4667
        },
        {
          "x": 0.0337,
          "y": 0.4667
        }
      ],
      "id": 10,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='11' data-category='paragraph' style='font-size:18px'>사람면역결핍바이러스(human immunodeficiency virus. HIV) 감염 초기에 감염단백구증과 비슷한 발열, 인후통, 근육통, 림프절 비대 등이 나타날 수 있습니다.<br>앱스타인-바 바이러스에 의한 감염단백구증은 점막(입안, 결막, 성기 주변) 궤양이 드물고, 피부 발진도 흔하지 않으나 항생제를 복용한 경우 자주 생깁니다.<br>사람면역결핍바이러스 감염증은 엘이 난 지 48- 72시간 안에 발진이 나타나는 경우가 더 혼합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0324,
          "y": 0.486
        },
        {
          "x": 0.6214,
          "y": 0.486
        },
        {
          "x": 0.6214,
          "y": 0.5233
        },
        {
          "x": 0.0324,
          "y": 0.5233
        }
      ],
      "id": 11,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='12' style='font-size:18px'>2. 거대세포바이러스 감염증(CMV감염증)</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0318,
          "y": 0.5435
        },
        {
          "x": 0.1887,
          "y": 0.5435
        },
        {
          "x": 0.1887,
          "y": 0.5559
        },
        {
          "x": 0.0318,
          "y": 0.5559
        }
      ],
      "id": 12,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='13' data-category='paragraph' style='font-size:18px'>거대세포바이러스(cytomegalovirus, CMV)는 엡스타인-바 바이러스에 의한 감염단백구증에 비해 발열이 주증상이며, 림프절 비대와 인후통은 덜 혼합니다. 간<br>효소 수치의 가벼운 증가는 자주 관찰되지만, 황달이나 심각한 간염 증상은 드물게 나타납니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.5762
        },
        {
          "x": 0.6231,
          "y": 0.5762
        },
        {
          "x": 0.6231,
          "y": 0.6012
        },
        {
          "x": 0.0321,
          "y": 0.6012
        }
      ],
      "id": 13,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='14' data-category='paragraph' style='font-size:16px'>3. 록소포자중증</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0325,
          "y": 0.6223
        },
        {
          "x": 0.0954,
          "y": 0.6223
        },
        {
          "x": 0.0954,
          "y": 0.633
        },
        {
          "x": 0.0325,
          "y": 0.633
        }
      ],
      "id": 14,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='15' data-category='paragraph' style='font-size:18px'>톡소포자중증은 톡소포자라고 불리는 기생중에 의한 감염증으로 발열과 림프절 비대가 특징입니다. 인후염은 거의 없으며, 거대세포바이러스나 앱스타인 -바<br>바이레스 감염 시 흔히 나타나는 간기능검사 이상이나 혈액검사 이상도 드뭅니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0315,
          "y": 0.6539
        },
        {
          "x": 0.6212,
          "y": 0.6539
        },
        {
          "x": 0.6212,
          "y": 0.6797
        },
        {
          "x": 0.0315,
          "y": 0.6797
        }
      ],
      "id": 15,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='16' data-category='paragraph' style='font-size:18px'>사람 헤르페스바이러스(Herpes simplex virus. HSV) 6형이나 7형에 의한 일차 감염증은 성인에서 드물지만, 림프절 비대 등 감염단백구증과 유사한 증상이<br>나타날 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0336,
          "y": 0.7318
        },
        {
          "x": 0.6212,
          "y": 0.7318
        },
        {
          "x": 0.6212,
          "y": 0.7571
        },
        {
          "x": 0.0336,
          "y": 0.7571
        }
      ],
      "id": 16,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<br><h1 id='17' style='font-size:18px'>4. 사람 헤르메스바이러스 감염증(HSV감염증)</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0317,
          "y": 0.6996
        },
        {
          "x": 0.2053,
          "y": 0.6996
        },
        {
          "x": 0.2053,
          "y": 0.7121
        },
        {
          "x": 0.0317,
          "y": 0.7121
        }
      ],
      "id": 17,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='18' style='font-size:22px'>개요-원인</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0336,
          "y": 0.7754
        },
        {
          "x": 0.0879,
          "y": 0.7754
        },
        {
          "x": 0.0879,
          "y": 0.7898
        },
        {
          "x": 0.0336,
          "y": 0.7898
        }
      ],
      "id": 18,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='19' data-category='paragraph' style='font-size:18px'>감염단핵구증의 90%는 엠스타인-바 바이러스에 의해 발생합니다. 엠스타인-바 바이러스는 감마 헤르페스바이러스에 속하며 크게 1형과 2형으로 구분됩니다. 두<br>가지 유형은 70- 85%의 염기서열 유사성을 가지고 있습니다. 1형은 전 세계에 퍼져 있고, 2형은 주로 아프리카에 분포합니다. 엠스타인-바 바이러스는 감염된<br>사람의 침으로 분비되어 전파됩니다. 증상이 나타나지 않은 성인이 신생아나 어린이 혹은 다른 성안에게 입을 맞줄 때 쉽게 전파될 수 있습니다. 밀접한 접촉이<br>없다면 전파되기 어렵습니다. 감염단백구증의 나머지 10%는 거대세포바이러스, 사람면역결핍바이러스, 톡소포자총, 사람 헤르페스바이러스 6형, B형<br>간염바이러스 등 다른 미생물에 의해 발생합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.033,
          "y": 0.7968
        },
        {
          "x": 0.622,
          "y": 0.7968
        },
        {
          "x": 0.622,
          "y": 0.8576
        },
        {
          "x": 0.033,
          "y": 0.8576
        }
      ],
      "id": 19,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='20' style='font-size:20px'>역학 및 통계</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0333,
          "y": 0.8761
        },
        {
          "x": 0.1014,
          "y": 0.8761
        },
        {
          "x": 0.1014,
          "y": 0.8911
        },
        {
          "x": 0.0333,
          "y": 0.8911
        }
      ],
      "id": 20,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='21' data-category='paragraph' style='font-size:18px'>감염단핵구증은 전 세계적으로 나타나는데 선진국에서는 청소년 및 젊은 성인에서 주로 발생합니다. 반면 우리나라, 일본, 중국 동부 등 극동아시아 지역에서는<br>어린 소아에게 많이 발생하며, 임상적으로 증상이 없거나 경한 것이 특징입니다. 국내 면역혈청학적 연구 결과, 모체에서 전달된 엡스타인-바 바이 러스 항체는<br>생후 7개월경에 완전히 소심되지만 생후 10개월부터 초감염이 시작되어 5세경에는 50%, 10세에 이르면 거의 모든 소아가 옙스타인-바 바이러스에 감염됩니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.9303
        },
        {
          "x": 0.6228,
          "y": 0.9303
        },
        {
          "x": 0.6228,
          "y": 0.9681
        },
        {
          "x": 0.0321,
          "y": 0.9681
        }
      ],
      "id": 21,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='22' data-category='paragraph' style='font-size:16px'>1. 역학</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0348,
          "y": 0.8986
        },
        {
          "x": 0.0639,
          "y": 0.8986
        },
        {
          "x": 0.0639,
          "y": 0.9096
        },
        {
          "x": 0.0348,
          "y": 0.9096
        }
      ],
      "id": 22,
      "page": 1
    },
    {
      "category": "header",
      "content": {
        "html": "<br><header id='23' style='font-size:14px'>2. 전파</header>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3678,
          "y": 0.0003
        },
        {
          "x": 0.3891,
          "y": 0.0003
        },
        {
          "x": 0.3891,
          "y": 0.0104
        },
        {
          "x": 0.3678,
          "y": 0.0104
        }
      ],
      "id": 23,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='24' data-category='paragraph' style='font-size:14px'>대표적으로 침과 같은 구강 분비물에 의한 전파, 모유수유에 의한 전파, 성접촉에 의한 전파가 가능합니다. 엡스타인-바 바이러스에 감염된 환자는 일반적으로<br>증상이 나타난 후 6개월까지 바이러스를 전파할 수 있습니다. 환자의 접촉자가 비접촉자에 비해 엡스타인-바 바이러스에 감염될 확률이 높지는 않은 것으로 되어<br>있어 관리가 필요한 전염병으로 분류되지는 않습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3664,
          "y": 0.029
        },
        {
          "x": 0.7535,
          "y": 0.029
        },
        {
          "x": 0.7535,
          "y": 0.0622
        },
        {
          "x": 0.3664,
          "y": 0.0622
        }
      ],
      "id": 24,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='25' data-category='paragraph' style='font-size:18px'>증상</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.0787
        },
        {
          "x": 0.3862,
          "y": 0.0787
        },
        {
          "x": 0.3862,
          "y": 0.092
        },
        {
          "x": 0.3683,
          "y": 0.092
        }
      ],
      "id": 25,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='26' data-category='paragraph' style='font-size:14px'>신생아나 소아는 엡스타인-바 바이러스에 감염되어도 대부분 증상이 없거나 가볍습니다. 후진국이나 개발도상국 혹은 위생 상태가 좋지 않은 환경에서는 대부분<br>신생아나 소아기에 엡스타인-바 바이러스에 감염되기 때문에 청소년이나 성인이 감염되는 경우는 거의 없습니다. 하지만 선진국이나 청결한 환경에 사는<br>사람들은 청소년기나 성인이 되어 엡스타인-바 바이러스에 처음 감염되는 경우가 흔하고, 이런 경우 증상을 동반한 감염단핵구증이 발생할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3669,
          "y": 0.1005
        },
        {
          "x": 0.7534,
          "y": 0.1005
        },
        {
          "x": 0.7534,
          "y": 0.133
        },
        {
          "x": 0.3669,
          "y": 0.133
        }
      ],
      "id": 26,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='27' data-category='paragraph' style='font-size:14px'>젊은 성인이 엡스타인-바 바이러스에 감염되면 4-6주간의 무증상 잠복기를 거쳐 피로감, 권태감 및 근육통이 약 1-2주 동안 지속됩니다. 이후 발열, 인후통 및<br>림프절 비대가 발생합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3664,
          "y": 0.1502
        },
        {
          "x": 0.7538,
          "y": 0.1502
        },
        {
          "x": 0.7538,
          "y": 0.1731
        },
        {
          "x": 0.3664,
          "y": 0.1731
        }
      ],
      "id": 27,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='28' data-category='paragraph' style='font-size:18px'>진단 및 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.3629
        },
        {
          "x": 0.4138,
          "y": 0.3629
        },
        {
          "x": 0.4138,
          "y": 0.3764
        },
        {
          "x": 0.3685,
          "y": 0.3764
        }
      ],
      "id": 28,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='29' data-category='paragraph' style='font-size:14px'>엡스타인-바 바이러스와 연관된 감염단핵구증은 청소년이나 젊은 성인에서 인후통, 발열, 권태감과 함께 림프절 비대와 인후염이 진찰로 확인되면 의심할 수<br>있습니다. 의사는 자세한 문진과 함께 진찰을 통해 환자의 증상과 징후를 평가합니다. 진찰로 감염단핵구증이 의심되면 엡스타인-바 바이러스에 대한 혈액 검사를<br>시행합니다. 혈액 검사에서 림프구수나 비정형 림프구수가 증가하고, 이종친화항체가 양성이면 감염단핵구증으로 진단할 수 있습니다. 그 외 엡스타인-바<br>바이러스 특이 항체검사가 필요하기도 합니다. 목 주변 림프절이 커지지 않거나 피로감이 없는 환자는 입 천장에 점 모양의 출혈이 있거나 비장이 커지는 경우<br>의심할 수 있습니다. 그러나 이런 증상이 있어 감염단핵구증이 의심되더라도 발열, 림프절 비대, 인후염이 있을 때는 화농성 사슬알균에 의한 세균성 인후염을<br>먼저 고려해야 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3672,
          "y": 0.3837
        },
        {
          "x": 0.7525,
          "y": 0.3837
        },
        {
          "x": 0.7525,
          "y": 0.4488
        },
        {
          "x": 0.3672,
          "y": 0.4488
        }
      ],
      "id": 29,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='30' data-category='paragraph' style='font-size:14px'>1. 문진</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.4671
        },
        {
          "x": 0.388,
          "y": 0.4671
        },
        {
          "x": 0.388,
          "y": 0.4783
        },
        {
          "x": 0.3689,
          "y": 0.4783
        }
      ],
      "id": 30,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='31' data-category='paragraph' style='font-size:14px'>열이 얼마나 나는지, 목이 따가운지, 아프고 부은 림프절이 있는지, 피부 발진이 있는지 등을 묻습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.368,
          "y": 0.4968
        },
        {
          "x": 0.6112,
          "y": 0.4968
        },
        {
          "x": 0.6112,
          "y": 0.5086
        },
        {
          "x": 0.368,
          "y": 0.5086
        }
      ],
      "id": 31,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='32' data-category='paragraph' style='font-size:14px'>2. 진찰</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3677,
          "y": 0.5273
        },
        {
          "x": 0.388,
          "y": 0.5273
        },
        {
          "x": 0.388,
          "y": 0.5384
        },
        {
          "x": 0.3677,
          "y": 0.5384
        }
      ],
      "id": 32,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='33' data-category='paragraph' style='font-size:14px'>감염단핵구증은 전신을 침범하는 질환이므로 전신을 진찰합니다. 입안을 진찰하여 인후염이 있는지, 편도가 커져 있는지 확인합니다. 목의 림프절을 포함하여<br>전신 림프절이 커지고 부었는지 확인합니다. 가슴을 청진하여 폐렴이나 흉수가 있는지 확인하고, 배에서 간이나 비장이 커졌는지를 확인합니다. 전신에 발진이<br>있는지도 확인합니다. 그 외에 신경증상이 있는 경우 신경학적 검사를 통해 마비가 동반되었는지 확인합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3668,
          "y": 0.5571
        },
        {
          "x": 0.7532,
          "y": 0.5571
        },
        {
          "x": 0.7532,
          "y": 0.591
        },
        {
          "x": 0.3668,
          "y": 0.591
        }
      ],
      "id": 33,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='34' data-category='paragraph' style='font-size:14px'>3. 피검사 소견</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3679,
          "y": 0.6088
        },
        {
          "x": 0.4057,
          "y": 0.6088
        },
        {
          "x": 0.4057,
          "y": 0.6201
        },
        {
          "x": 0.3679,
          "y": 0.6201
        }
      ],
      "id": 34,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='35' data-category='paragraph' style='font-size:14px'>1) 혈액검사 이상</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3686,
          "y": 0.6392
        },
        {
          "x": 0.4114,
          "y": 0.6392
        },
        {
          "x": 0.4114,
          "y": 0.6504
        },
        {
          "x": 0.3686,
          "y": 0.6504
        }
      ],
      "id": 35,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='36' data-category='paragraph' style='font-size:14px'>가장 흔한 검사 이상은 말초 혈액에서 림프구수 증가(림프구증가증)입니다. 림프구증가증은 말초혈액 림프구의 절대수가 4,500개/uL 이상, 혹은 말초혈액<br>도말검사에서 림프구 분획이 백혈구의 50% 이상일 때로 정의됩니다. 모양이 이상한 비정형 림프구가 전체 림프구수의 10% 이상인 것을 말초혈액 도말검사에서<br>확인할 수 있습니다. 정상인의 말초혈액에서 총 백혈구수는 4,000-10,000개/uL이나, 감염단핵구증에서는 12,000-18,000개/uL로 증가합니다. 일부<br>환자에서는 경미한 호중구감소증과 혈소판감소증이 나타날 수 있습니다. 이러한 현상은 대개 특별한 치료제를 투여하지 않아도 저절로 회복됩니다. 드물게<br>용혈성 빈혈, 혈소판감소증, 악성 빈혈이나 혈전저혈소판혈증자색반병, 용혈요독증후군, 파종혈관내응고 등이 발생할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3665,
          "y": 0.6539
        },
        {
          "x": 0.7536,
          "y": 0.6539
        },
        {
          "x": 0.7536,
          "y": 0.7081
        },
        {
          "x": 0.3665,
          "y": 0.7081
        }
      ],
      "id": 36,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='37' data-category='paragraph' style='font-size:14px'>2) 간기능 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.7274
        },
        {
          "x": 0.4057,
          "y": 0.7274
        },
        {
          "x": 0.4057,
          "y": 0.738
        },
        {
          "x": 0.3684,
          "y": 0.738
        }
      ],
      "id": 37,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='38' data-category='paragraph' style='font-size:14px'>간효소 중 하나인 아미노 전이효소치의 상승은 많은 환자에서 관찰되며 대개 저절로 좋아집니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3682,
          "y": 0.7424
        },
        {
          "x": 0.5971,
          "y": 0.7424
        },
        {
          "x": 0.5971,
          "y": 0.7537
        },
        {
          "x": 0.3682,
          "y": 0.7537
        }
      ],
      "id": 38,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='39' data-category='paragraph' style='font-size:14px'>4. 감별진단</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3682,
          "y": 0.7725
        },
        {
          "x": 0.3994,
          "y": 0.7725
        },
        {
          "x": 0.3994,
          "y": 0.7836
        },
        {
          "x": 0.3682,
          "y": 0.7836
        }
      ],
      "id": 39,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='40' data-category='paragraph' style='font-size:14px'>발열, 인후통, 림프절 비대 등은 감염단핵구증에서만 나타나는 특이한 증상은 아닙니다. 엡스타인-바 바이러스 외에 세균성 인후염을 잘 일으키는 화농성<br>사슬알균 감염증이나 거대세포바이러스, 사람면역결핍바이러스 등 다른 바이러스 감염증에서도 나타날 수 있습니다. 비정형 림프구가 나타나는 단핵구 증후군은<br>감염증 외에 항경련제인 페니토인, 카바마제핀, 항결핵제인 이소니아지드, 항생제인 미노사이클린 등 약제에 의해 발생하기도 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.366,
          "y": 0.8027
        },
        {
          "x": 0.7527,
          "y": 0.8027
        },
        {
          "x": 0.7527,
          "y": 0.8363
        },
        {
          "x": 0.366,
          "y": 0.8363
        }
      ],
      "id": 40,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='41' data-category='paragraph' style='font-size:14px'>5. 진단에 도움을 주는 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.8547
        },
        {
          "x": 0.4359,
          "y": 0.8547
        },
        {
          "x": 0.4359,
          "y": 0.8661
        },
        {
          "x": 0.3685,
          "y": 0.8661
        }
      ],
      "id": 41,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='42' data-category='paragraph' style='font-size:14px'>1) 혈액검사 소견</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3695,
          "y": 0.8848
        },
        {
          "x": 0.4119,
          "y": 0.8848
        },
        {
          "x": 0.4119,
          "y": 0.8953
        },
        {
          "x": 0.3695,
          "y": 0.8953
        }
      ],
      "id": 42,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='43' data-category='paragraph' style='font-size:14px'>가장 흔한 검사 이상 소견은 말초 혈액에서 림프구수 증가입니다. 말초혈액 도말검사에서 비정형 림프구가 전체 림프구수의 10% 이상을 차지하면 진단에 도움이<br>됩니다. 하지만 비정형 림프구는 감염단핵구증 외에도 톡소플라즈마 감염, 풍진, 장미진, 볼거리, 거대세포바이러스 등 바이러스 감염증과 급성<br>사람면역결핍바이러스 증후군, 급성 바이러스 간염 등 다른 감염질환에서도 나타날 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3679,
          "y": 0.8988
        },
        {
          "x": 0.7542,
          "y": 0.8988
        },
        {
          "x": 0.7542,
          "y": 0.9331
        },
        {
          "x": 0.3679,
          "y": 0.9331
        }
      ],
      "id": 43,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='44' data-category='paragraph' style='font-size:14px'>2) 이종친화항체(heterophil antibody) 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.9518
        },
        {
          "x": 0.4763,
          "y": 0.9518
        },
        {
          "x": 0.4763,
          "y": 0.9626
        },
        {
          "x": 0.3689,
          "y": 0.9626
        }
      ],
      "id": 44,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='45' data-category='paragraph' style='font-size:14px'>이종친화항체는 서로 다른 종의 항원에 반응하는 항체로, 이종친화항체 검사는 환자의 혈청이 양, 말, 소, 염소의 적혈구와 반응하여 응집하는지를 확인하는<br>검사법입니다. 감염단핵구증의 증상이 있는 환자에서 이종친화항체 검사 결과가 양성이면 감염단핵구증으로 확진할 수 있습니다. 증상이 있고 이종친화항체가<br>양성으로 확인된 환자는 엡스타인-바 바이러스에 대한 특이 항체 검사가 필요 없습니다. 일부 환자는 임상적으로 의심은 되는데 검사 결과가 음성으로 나오기도</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.367,
          "y": 0.9653
        },
        {
          "x": 0.7527,
          "y": 0.9653
        },
        {
          "x": 0.7527,
          "y": 1.0122
        },
        {
          "x": 0.367,
          "y": 1.0122
        }
      ],
      "id": 45,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='46' data-category='paragraph' style='font-size:16px'>합니다. 증상이 시작되는 첫 주에 위음성(감염단핵구증이지만 검사 결과가 음성인 경우)이 가장 흔하여 25%에 달하고, 2주째는 5-10%, 3주째는 5%로<br>떨어집니다. 따라서, 임상적으로 감염단핵구증이 강력히 의심되면 검사를 다시 하여 양성으로 바뀌는지 확인하는 것이 좋습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3661,
          "y": 0.015
        },
        {
          "x": 0.7544,
          "y": 0.015
        },
        {
          "x": 0.7544,
          "y": 0.0391
        },
        {
          "x": 0.3661,
          "y": 0.0391
        }
      ],
      "id": 46,
      "page": 3
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='47' data-category='list' style='font-size:16px'>3) 엡스타인-바 바이러스 특이 항체<br>감염단핵구증이 의심되지만 이종친화항체가 음성인 경우 엡스타인-바 바이러스에 대한 특이 항체를 검사합니다. 바이러스 캡시드 항원에 대한 면역글로불린<br>M(Immunoglobulin M, IgM)과 면역글로불린 G(Immunoglobulin G, IgG) 항체는 감염단핵구증 진단에 유용한 검사법입니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3663,
          "y": 0.0584
        },
        {
          "x": 0.7528,
          "y": 0.0584
        },
        {
          "x": 0.7528,
          "y": 0.0955
        },
        {
          "x": 0.3663,
          "y": 0.0955
        }
      ],
      "id": 47,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='48' data-category='paragraph' style='font-size:16px'>(1) 바이러스 캡시드 항원(virus capsid antibody, EBV VCA)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3688,
          "y": 0.1134
        },
        {
          "x": 0.5161,
          "y": 0.1134
        },
        {
          "x": 0.5161,
          "y": 0.1251
        },
        {
          "x": 0.3688,
          "y": 0.1251
        }
      ],
      "id": 48,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='49' data-category='paragraph' style='font-size:16px'>엡스타인-바 바이러스 캡시드 항원에 대한 IgM과 IgG 항체는 임상 증상이 나타나는 초기에 대개 양성으로 나타납니다. IgM 항체는 증상 발생 후 3개월까지<br>나타나기도 합니다. 따라서, IgM 항체는 급성 감염증의 좋은 지표입니다. IgG 항체는 평생 지속됩니다. 따라서 급성 감염증의 좋은 지표는 아니지만 감염된 적이<br>있다는 증거가 됩니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3677,
          "y": 0.1285
        },
        {
          "x": 0.753,
          "y": 0.1285
        },
        {
          "x": 0.753,
          "y": 0.1619
        },
        {
          "x": 0.3677,
          "y": 0.1619
        }
      ],
      "id": 49,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='50' data-category='paragraph' style='font-size:16px'>(2) 핵 항원(nuclear antibody, EBNA)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3691,
          "y": 0.1804
        },
        {
          "x": 0.4617,
          "y": 0.1804
        },
        {
          "x": 0.4617,
          "y": 0.1916
        },
        {
          "x": 0.3691,
          "y": 0.1916
        }
      ],
      "id": 50,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='51' data-category='paragraph' style='font-size:16px'>엡스타인-바 바이러스의 핵 항원에 대한 IgM 항체가 있는 경우 급성 엡스타인-바 바이러스 감염증으로 진단할 수 있습니다. IgG 항체는 증상 발현 6-12주에<br>나타나기 시작하여 평생 지속됩니다. 따라서, 시간이 지나면서 엡스타인-바 바이러스 핵 항원 IgG가 음성에서 양성으로 바뀌면 확진할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.1953
        },
        {
          "x": 0.753,
          "y": 0.1953
        },
        {
          "x": 0.753,
          "y": 0.2182
        },
        {
          "x": 0.3673,
          "y": 0.2182
        }
      ],
      "id": 51,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='52' data-category='paragraph' style='font-size:16px'>(3) 초기 항원(early antigen, EA)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3686,
          "y": 0.2367
        },
        {
          "x": 0.4506,
          "y": 0.2367
        },
        {
          "x": 0.4506,
          "y": 0.2474
        },
        {
          "x": 0.3686,
          "y": 0.2474
        }
      ],
      "id": 52,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='53' data-category='paragraph' style='font-size:16px'>초기 항원에 대한 IgG 항체는 증상이 발생하는 시점에 양성으로 나타납니다. 초기 항원에는 D항원에 대한 초기 IgG 항체와 R항원에 대한 초기 IgG 항체 등 두<br>가지가 있습니다. D항원에 대한 항체는 감염 초기에 역가가 상승했다가 회복기를 거치면서 음성으로 변합니다. 그러나 대다수 환자에서 나타나는 항체는<br>아니므로, D항원에 대한 항체가 음성이라도 급성 엡스타인-바 바이러스 감염증을 배제할 수 없습니다. R항원에 대한 IgG 항체는 일부 환자만 양성으로<br>나타납니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.25
        },
        {
          "x": 0.7527,
          "y": 0.25
        },
        {
          "x": 0.7527,
          "y": 0.2951
        },
        {
          "x": 0.3673,
          "y": 0.2951
        }
      ],
      "id": 53,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='54' data-category='paragraph' style='font-size:16px'>4) 엡스타인-바 바이러스 중합효소연쇄반응(polymerase chain reaction, PCR)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.369,
          "y": 0.3141
        },
        {
          "x": 0.5605,
          "y": 0.3141
        },
        {
          "x": 0.5605,
          "y": 0.3249
        },
        {
          "x": 0.369,
          "y": 0.3249
        }
      ],
      "id": 54,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='55' data-category='paragraph' style='font-size:16px'>혈액으로 중합효소연쇄반응을 검사하여 엡스타인-바 바이러스 유전자를 확인할 수 있습니다. 중합효소연쇄반응은 원하는 유전자를 복제·증폭시키는<br>분자생물학적 기술입니다. 혈액 속바이러스 유전자를 검사하여 바이러스가 얼마나 있는지 정량합니다. 그러나 병원에서 감염단핵구증을 진단하기 위해 이 검사가<br>필요하지는 않습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.3287
        },
        {
          "x": 0.7527,
          "y": 0.3287
        },
        {
          "x": 0.7527,
          "y": 0.3612
        },
        {
          "x": 0.3673,
          "y": 0.3612
        }
      ],
      "id": 55,
      "page": 3
    },
    {
      "category": "header",
      "content": {
        "html": "<header id='56' style='font-size:20px'>치료</header>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.3789
        },
        {
          "x": 0.3864,
          "y": 0.3789
        },
        {
          "x": 0.3864,
          "y": 0.3922
        },
        {
          "x": 0.3683,
          "y": 0.3922
        }
      ],
      "id": 56,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='57' data-category='paragraph' style='font-size:16px'>1. 대증치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3695,
          "y": 0.3991
        },
        {
          "x": 0.3988,
          "y": 0.3991
        },
        {
          "x": 0.3988,
          "y": 0.4101
        },
        {
          "x": 0.3695,
          "y": 0.4101
        }
      ],
      "id": 57,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='58' data-category='paragraph' style='font-size:16px'>감염단핵구증의 주된 치료는 증상을 가라앉히는 대증치료입니다. 발열, 인후통, 근육통, 권태감이 심한 경우 진통해열제가 도움이 됩니다. 충분한 수분과 영양<br>섭취도 중요하며, 휴식을 취하는 것이 좋습니다. 스테로이드 치료를 하는 경우가 있는데, 합병증이 생기지 않은 감염단핵구증에는 사용하지 않습니다.<br>스테로이드를 불필요하게 사용하면 이차 세균감염증이 잘 발생하기 때문입니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3675,
          "y": 0.4288
        },
        {
          "x": 0.7532,
          "y": 0.4288
        },
        {
          "x": 0.7532,
          "y": 0.4612
        },
        {
          "x": 0.3675,
          "y": 0.4612
        }
      ],
      "id": 58,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='59' data-category='paragraph' style='font-size:16px'>2. 합병증이 동반된 감염단핵구증의 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.481
        },
        {
          "x": 0.4677,
          "y": 0.481
        },
        {
          "x": 0.4677,
          "y": 0.4922
        },
        {
          "x": 0.3684,
          "y": 0.4922
        }
      ],
      "id": 59,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='60' data-category='paragraph' style='font-size:16px'>편도가 심하게 부어 기도가 막힐 위험이 있는 경우 스테로이드를 사용합니다. 매일 프레드니솔론 40~60 mg을 2-3일 투여한 후, 1-2주에 걸쳐 천천히 줄입니다.<br>그 외에 자가면역 용혈성 빈혈, 심한 혈소판감소증, 간부전을 동반한 심한 간염이 있는 경우에도 스테로이드 치료를 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3671,
          "y": 0.5111
        },
        {
          "x": 0.7515,
          "y": 0.5111
        },
        {
          "x": 0.7515,
          "y": 0.5334
        },
        {
          "x": 0.3671,
          "y": 0.5334
        }
      ],
      "id": 60,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='61' data-category='paragraph' style='font-size:16px'>3. 항바이러스제 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3679,
          "y": 0.5521
        },
        {
          "x": 0.4226,
          "y": 0.5521
        },
        {
          "x": 0.4226,
          "y": 0.563
        },
        {
          "x": 0.3679,
          "y": 0.563
        }
      ],
      "id": 61,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='62' data-category='paragraph' style='font-size:16px'>아시클로버(acyclovir)는 항바이러스제로 엡스타인-바 바이러스 DNA 유전자중합효소를 억제하여 바이러스 증식을 막습니다. 항바이러스제를 투여하면<br>입안에서 바이러스 배출이 억제되지만, 병의 심한 정도나 증상의 기간을 감소시키지 않으며 궁극적인 예후에도 영향을 주지 않습니다. 따라서 감염단핵구증<br>치료로 항바이러스제 투여는 추천되지 않습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3677,
          "y": 0.582
        },
        {
          "x": 0.7529,
          "y": 0.582
        },
        {
          "x": 0.7529,
          "y": 0.6145
        },
        {
          "x": 0.3677,
          "y": 0.6145
        }
      ],
      "id": 62,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='63' data-category='paragraph' style='font-size:20px'>합병증</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3686,
          "y": 0.6317
        },
        {
          "x": 0.3941,
          "y": 0.6317
        },
        {
          "x": 0.3941,
          "y": 0.6447
        },
        {
          "x": 0.3686,
          "y": 0.6447
        }
      ],
      "id": 63,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='64' data-category='paragraph' style='font-size:16px'>지속적인 피곤함과 불편감, 신체 장애 등의 증상이 수 주에서 6개월까지 호전과 악화를 반복할 수 있습니다. 드물게 비장 파열, 2차 감염, 간기능 부전, 심근염이<br>발생할 수 있으며, 이러한 경우에 사망하기도 합니다. 이런 중증 합병증은 소아에서는 극히 드물며 젊은 성인에서 많이 나타납니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3671,
          "y": 0.6525
        },
        {
          "x": 0.7532,
          "y": 0.6525
        },
        {
          "x": 0.7532,
          "y": 0.6751
        },
        {
          "x": 0.3671,
          "y": 0.6751
        }
      ],
      "id": 64,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='65' data-category='paragraph' style='font-size:20px'>참고문헌</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.6918
        },
        {
          "x": 0.4018,
          "y": 0.6918
        },
        {
          "x": 0.4018,
          "y": 0.7046
        },
        {
          "x": 0.3683,
          "y": 0.7046
        }
      ],
      "id": 65,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='66' data-category='paragraph' style='font-size:16px'>1. Section 4-4. 엡스타인 바이러스, 감염학, 2014</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.7125
        },
        {
          "x": 0.4935,
          "y": 0.7125
        },
        {
          "x": 0.4935,
          "y": 0.7237
        },
        {
          "x": 0.3683,
          "y": 0.7237
        }
      ],
      "id": 66,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='67' data-category='paragraph' style='font-size:16px'>3. Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015;390(Pt 1):211-240. doi:10.1007/978-3-<br>319-22822-8_9</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3676,
          "y": 0.7839
        },
        {
          "x": 0.7509,
          "y": 0.7839
        },
        {
          "x": 0.7509,
          "y": 0.8037
        },
        {
          "x": 0.3676,
          "y": 0.8037
        }
      ],
      "id": 67,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='68' data-category='paragraph' style='font-size:16px'>2. Fafi-Kremer S, Morand P, Brion JP, et al. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis.<br>2005;191(6):985-989. doi:10.1086/428097</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.368,
          "y": 0.7428
        },
        {
          "x": 0.7501,
          "y": 0.7428
        },
        {
          "x": 0.7501,
          "y": 0.764
        },
        {
          "x": 0.368,
          "y": 0.764
        }
      ],
      "id": 68,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='69' data-category='paragraph' style='font-size:18px'>본 공공저작물은 공공누리 \"출처표시+상업적이용금지+변경금지\" 조건에 따라 이용할 수 있<br>습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5039,
          "y": 0.8289
        },
        {
          "x": 0.7396,
          "y": 0.8289
        },
        {
          "x": 0.7396,
          "y": 0.8539
        },
        {
          "x": 0.5039,
          "y": 0.8539
        }
      ],
      "id": 69,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='70' data-category='paragraph' style='font-size:14px'> 목록</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5531,
          "y": 0.8769
        },
        {
          "x": 0.5684,
          "y": 0.8769
        },
        {
          "x": 0.5684,
          "y": 0.8841
        },
        {
          "x": 0.5531,
          "y": 0.8841
        }
      ],
      "id": 70,
      "page": 3
    },
    {
      "category": "header",
      "content": {
        "html": "<br><header id='71' style='font-size:18px'>개인정보처리방침 개인정보이용안내 저작권정책 및 웹접근성</header>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.264,
          "y": 0
        },
        {
          "x": 0.4362,
          "y": 0
        },
        {
          "x": 0.4362,
          "y": 0.0104
        },
        {
          "x": 0.264,
          "y": 0.0104
        }
      ],
      "id": 71,
      "page": 4
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='72' data-category='list' style='font-size:18px'>[ 28159 ] 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 오송보건의료행정타운 내 질병관리청<br>문의사항: 02-2030-6602 (평일 9:00-17:00, 12:00-13:00 제외) / 관리자 이메일 : nhis@korea.kr</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2638,
          "y": 0.029
        },
        {
          "x": 0.5074,
          "y": 0.029
        },
        {
          "x": 0.5074,
          "y": 0.0528
        },
        {
          "x": 0.2638,
          "y": 0.0528
        }
      ],
      "id": 72,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='73' data-category='paragraph' style='font-size:14px'>COPYRIGHT @ 2024 질병관리청. ALL RIGHT RESERVED</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2652,
          "y": 0.0526
        },
        {
          "x": 0.3839,
          "y": 0.0526
        },
        {
          "x": 0.3839,
          "y": 0.0597
        },
        {
          "x": 0.2652,
          "y": 0.0597
        }
      ],
      "id": 73,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='74' data-category='paragraph' style='font-size:18px'>※ 본 페이지에서 제공하는 내용은 참고사항일 뿐 게시물에 대한 법적책임은 없음을 밝혀드립니다. 자세한 내용은 전문가와 상담하시기 바랍니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2655,
          "y": 0.0785
        },
        {
          "x": 0.617,
          "y": 0.0785
        },
        {
          "x": 0.617,
          "y": 0.0913
        },
        {
          "x": 0.2655,
          "y": 0.0913
        }
      ],
      "id": 74,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='75' data-category='paragraph' style='font-size:18px'>해외기관  유관기관  정부기관 </p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5544,
          "y": 0.0335
        },
        {
          "x": 0.7408,
          "y": 0.0335
        },
        {
          "x": 0.7408,
          "y": 0.0422
        },
        {
          "x": 0.5544,
          "y": 0.0422
        }
      ],
      "id": 75,
      "page": 4
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='76'><img alt=\"\" data-coord=\"top-left:(2150,140); bottom-right:(2260,224)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.7168,
          "y": 0.06
        },
        {
          "x": 0.7536,
          "y": 0.06
        },
        {
          "x": 0.7536,
          "y": 0.0956
        },
        {
          "x": 0.7168,
          "y": 0.0956
        }
      ],
      "id": 76,
      "page": 4
    }
  ],
  "merged_elements": [],
  "model": "document-parse-250116",
  "ocr": true,
  "usage": {
    "pages": 4
  }
}